Compare Amphastar Pharmaceuticals Inc (AMPH) vs Seagate Technology Holdings PLC (STX) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Seagate Technology (STX) trades at $910.34, up 2.28% with strong momentum driven by AI infrastructure demand. The stock shows impressive fundamental improvement with revenue growth from $6.6B to $9.1B and net income surging to $1.47B in 2025. Technical indicators are mixed with bullish moving averages but neutral oscillators, while analyst sentiment remains positive with a $981.43 consensus target representing 7.8% upside potential.

STX presents compelling growth prospects as AI-driven storage demand accelerates, supported by three consecutive earnings beats and expanding margins. Key risks include high valuation multiples (P/E 86.37), significant debt levels, and competitive pressures in the storage market. The company's positioning in AI infrastructure and strong institutional support suggest continued upside potential despite elevated valuation concerns.